Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis.
Identifieur interne : 002926 ( Main/Exploration ); précédent : 002925; suivant : 002927Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis.
Auteurs : P. Rutgeerts [Belgique] ; B G Feagan [Canada] ; C W Marano [États-Unis] ; L. Padgett [États-Unis] ; R. Strauss [États-Unis] ; J. Johanns [États-Unis] ; O J Adedokun [États-Unis] ; C. Guzzo [États-Unis] ; H. Zhang [États-Unis] ; J-F Colombel [France] ; W. Reinisch [Autriche] ; P R Gibson [Australie] ; W J Sandborn [États-Unis]Source :
- Alimentary pharmacology & therapeutics [ 1365-2036 ] ; 2015.
Descripteurs français
- KwdFr :
- Administration par voie intraveineuse, Adulte, Adulte d'âge moyen, Anticorps monoclonaux (administration et posologie), Anticorps monoclonaux (usage thérapeutique), Facteur de nécrose tumorale alpha (antagonistes et inhibiteurs), Femelle, Humains, Indice de gravité médicale, Injections sous-cutanées, Mâle, Méthode en double aveugle, Rectocolite hémorragique (traitement médicamenteux), Relation dose-effet des médicaments, Résultat thérapeutique.
- MESH :
- administration et posologie : Anticorps monoclonaux.
- antagonistes et inhibiteurs : Facteur de nécrose tumorale alpha.
- traitement médicamenteux : Rectocolite hémorragique.
- usage thérapeutique : Anticorps monoclonaux.
- Administration par voie intraveineuse, Adulte, Adulte d'âge moyen, Femelle, Humains, Indice de gravité médicale, Injections sous-cutanées, Mâle, Méthode en double aveugle, Relation dose-effet des médicaments, Résultat thérapeutique.
English descriptors
- KwdEn :
- Administration, Intravenous, Adult, Antibodies, Monoclonal (administration & dosage), Antibodies, Monoclonal (therapeutic use), Colitis, Ulcerative (drug therapy), Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Injections, Subcutaneous, Male, Middle Aged, Severity of Illness Index, Treatment Outcome, Tumor Necrosis Factor-alpha (antagonists & inhibitors).
- MESH :
- chemical , administration & dosage : Antibodies, Monoclonal.
- chemical , antagonists & inhibitors : Tumor Necrosis Factor-alpha.
- chemical , therapeutic use : Antibodies, Monoclonal.
- drug therapy : Colitis, Ulcerative.
- Administration, Intravenous, Adult, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Injections, Subcutaneous, Male, Middle Aged, Severity of Illness Index, Treatment Outcome.
Abstract
Tumour necrosis factor alpha (TNFα)-antagonism effectively treats ulcerative colitis (UC). The golimumab clinical programme evaluated subcutaneous (SC) and intravenous (IV) induction, and SC maintenance regimens, in TNFα-antagonist-naïve patients with moderate-to-severe active UC despite conventional treatment.
DOI: 10.1111/apt.13291
PubMed: 26119226
Affiliations:
- Australie, Autriche, Belgique, Canada, France, États-Unis
- Californie, Pennsylvanie, Vienne (Autriche)
- Vienne (Autriche)
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002A19
- to stream PubMed, to step Curation: 002949
- to stream PubMed, to step Checkpoint: 002949
- to stream Ncbi, to step Merge: 002770
- to stream Ncbi, to step Curation: 002770
- to stream Ncbi, to step Checkpoint: 002770
- to stream Main, to step Merge: 002926
- to stream Main, to step Curation: 002926
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis.</title><author><name sortKey="Rutgeerts, P" sort="Rutgeerts, P" uniqKey="Rutgeerts P" first="P" last="Rutgeerts">P. Rutgeerts</name><affiliation wicri:level="1"><nlm:affiliation>University Hospital, Gasthuisberg, Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>University Hospital, Gasthuisberg, Leuven</wicri:regionArea><wicri:noRegion>Leuven</wicri:noRegion></affiliation></author><author><name sortKey="Feagan, B G" sort="Feagan, B G" uniqKey="Feagan B" first="B G" last="Feagan">B G Feagan</name><affiliation wicri:level="1"><nlm:affiliation>Robarts Research Institute, University of Western Ontario, London, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Robarts Research Institute, University of Western Ontario, London, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author><author><name sortKey="Marano, C W" sort="Marano, C W" uniqKey="Marano C" first="C W" last="Marano">C W Marano</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Padgett, L" sort="Padgett, L" uniqKey="Padgett L" first="L" last="Padgett">L. Padgett</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Strauss, R" sort="Strauss, R" uniqKey="Strauss R" first="R" last="Strauss">R. Strauss</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Johanns, J" sort="Johanns, J" uniqKey="Johanns J" first="J" last="Johanns">J. Johanns</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Adedokun, O J" sort="Adedokun, O J" uniqKey="Adedokun O" first="O J" last="Adedokun">O J Adedokun</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Guzzo, C" sort="Guzzo, C" uniqKey="Guzzo C" first="C" last="Guzzo">C. Guzzo</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Zhang, H" sort="Zhang, H" uniqKey="Zhang H" first="H" last="Zhang">H. Zhang</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Colombel, J F" sort="Colombel, J F" uniqKey="Colombel J" first="J-F" last="Colombel">J-F Colombel</name><affiliation wicri:level="1"><nlm:affiliation>Hôpital Claude Huriez, Lille Cedex, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hôpital Claude Huriez, Lille Cedex</wicri:regionArea><wicri:noRegion>Lille Cedex</wicri:noRegion><wicri:noRegion>Lille Cedex</wicri:noRegion></affiliation></author><author><name sortKey="Reinisch, W" sort="Reinisch, W" uniqKey="Reinisch W" first="W" last="Reinisch">W. Reinisch</name><affiliation wicri:level="3"><nlm:affiliation>Universitätsklinik für Innere Medizin IV, Vienna, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Universitätsklinik für Innere Medizin IV, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author><author><name sortKey="Gibson, P R" sort="Gibson, P R" uniqKey="Gibson P" first="P R" last="Gibson">P R Gibson</name><affiliation wicri:level="1"><nlm:affiliation>Alfred Hospital, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Alfred Hospital, Melbourne, VIC</wicri:regionArea><wicri:noRegion>VIC</wicri:noRegion></affiliation></author><author><name sortKey="Sandborn, W J" sort="Sandborn, W J" uniqKey="Sandborn W" first="W J" last="Sandborn">W J Sandborn</name><affiliation wicri:level="2"><nlm:affiliation>University of California San Diego, La Jolla, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of California San Diego, La Jolla, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26119226</idno><idno type="pmid">26119226</idno><idno type="doi">10.1111/apt.13291</idno><idno type="wicri:Area/PubMed/Corpus">002A19</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002A19</idno><idno type="wicri:Area/PubMed/Curation">002949</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002949</idno><idno type="wicri:Area/PubMed/Checkpoint">002949</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002949</idno><idno type="wicri:Area/Ncbi/Merge">002770</idno><idno type="wicri:Area/Ncbi/Curation">002770</idno><idno type="wicri:Area/Ncbi/Checkpoint">002770</idno><idno type="wicri:Area/Main/Merge">002926</idno><idno type="wicri:Area/Main/Curation">002926</idno><idno type="wicri:Area/Main/Exploration">002926</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis.</title><author><name sortKey="Rutgeerts, P" sort="Rutgeerts, P" uniqKey="Rutgeerts P" first="P" last="Rutgeerts">P. Rutgeerts</name><affiliation wicri:level="1"><nlm:affiliation>University Hospital, Gasthuisberg, Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>University Hospital, Gasthuisberg, Leuven</wicri:regionArea><wicri:noRegion>Leuven</wicri:noRegion></affiliation></author><author><name sortKey="Feagan, B G" sort="Feagan, B G" uniqKey="Feagan B" first="B G" last="Feagan">B G Feagan</name><affiliation wicri:level="1"><nlm:affiliation>Robarts Research Institute, University of Western Ontario, London, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Robarts Research Institute, University of Western Ontario, London, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author><author><name sortKey="Marano, C W" sort="Marano, C W" uniqKey="Marano C" first="C W" last="Marano">C W Marano</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Padgett, L" sort="Padgett, L" uniqKey="Padgett L" first="L" last="Padgett">L. Padgett</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Strauss, R" sort="Strauss, R" uniqKey="Strauss R" first="R" last="Strauss">R. Strauss</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Johanns, J" sort="Johanns, J" uniqKey="Johanns J" first="J" last="Johanns">J. Johanns</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Adedokun, O J" sort="Adedokun, O J" uniqKey="Adedokun O" first="O J" last="Adedokun">O J Adedokun</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Guzzo, C" sort="Guzzo, C" uniqKey="Guzzo C" first="C" last="Guzzo">C. Guzzo</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Zhang, H" sort="Zhang, H" uniqKey="Zhang H" first="H" last="Zhang">H. Zhang</name><affiliation wicri:level="2"><nlm:affiliation>Janssen Research & Development, LLC, Spring House, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Janssen Research & Development, LLC, Spring House, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Colombel, J F" sort="Colombel, J F" uniqKey="Colombel J" first="J-F" last="Colombel">J-F Colombel</name><affiliation wicri:level="1"><nlm:affiliation>Hôpital Claude Huriez, Lille Cedex, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hôpital Claude Huriez, Lille Cedex</wicri:regionArea><wicri:noRegion>Lille Cedex</wicri:noRegion><wicri:noRegion>Lille Cedex</wicri:noRegion></affiliation></author><author><name sortKey="Reinisch, W" sort="Reinisch, W" uniqKey="Reinisch W" first="W" last="Reinisch">W. Reinisch</name><affiliation wicri:level="3"><nlm:affiliation>Universitätsklinik für Innere Medizin IV, Vienna, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Universitätsklinik für Innere Medizin IV, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author><author><name sortKey="Gibson, P R" sort="Gibson, P R" uniqKey="Gibson P" first="P R" last="Gibson">P R Gibson</name><affiliation wicri:level="1"><nlm:affiliation>Alfred Hospital, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Alfred Hospital, Melbourne, VIC</wicri:regionArea><wicri:noRegion>VIC</wicri:noRegion></affiliation></author><author><name sortKey="Sandborn, W J" sort="Sandborn, W J" uniqKey="Sandborn W" first="W J" last="Sandborn">W J Sandborn</name><affiliation wicri:level="2"><nlm:affiliation>University of California San Diego, La Jolla, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of California San Diego, La Jolla, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author></analytic><series><title level="j">Alimentary pharmacology & therapeutics</title><idno type="eISSN">1365-2036</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Intravenous</term><term>Adult</term><term>Antibodies, Monoclonal (administration & dosage)</term><term>Antibodies, Monoclonal (therapeutic use)</term><term>Colitis, Ulcerative (drug therapy)</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Injections, Subcutaneous</term><term>Male</term><term>Middle Aged</term><term>Severity of Illness Index</term><term>Treatment Outcome</term><term>Tumor Necrosis Factor-alpha (antagonists & inhibitors)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie intraveineuse</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps monoclonaux (administration et posologie)</term><term>Anticorps monoclonaux (usage thérapeutique)</term><term>Facteur de nécrose tumorale alpha (antagonistes et inhibiteurs)</term><term>Femelle</term><term>Humains</term><term>Indice de gravité médicale</term><term>Injections sous-cutanées</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Rectocolite hémorragique (traitement médicamenteux)</term><term>Relation dose-effet des médicaments</term><term>Résultat thérapeutique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antibodies, Monoclonal</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Tumor Necrosis Factor-alpha</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anticorps monoclonaux</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Facteur de nécrose tumorale alpha</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Colitis, Ulcerative</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Rectocolite hémorragique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticorps monoclonaux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Intravenous</term><term>Adult</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Injections, Subcutaneous</term><term>Male</term><term>Middle Aged</term><term>Severity of Illness Index</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par voie intraveineuse</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Indice de gravité médicale</term><term>Injections sous-cutanées</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Relation dose-effet des médicaments</term><term>Résultat thérapeutique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Tumour necrosis factor alpha (TNFα)-antagonism effectively treats ulcerative colitis (UC). The golimumab clinical programme evaluated subcutaneous (SC) and intravenous (IV) induction, and SC maintenance regimens, in TNFα-antagonist-naïve patients with moderate-to-severe active UC despite conventional treatment.</div></front></TEI><affiliations><list><country><li>Australie</li><li>Autriche</li><li>Belgique</li><li>Canada</li><li>France</li><li>États-Unis</li></country><region><li>Californie</li><li>Pennsylvanie</li><li>Vienne (Autriche)</li></region><settlement><li>Vienne (Autriche)</li></settlement></list><tree><country name="Belgique"><noRegion><name sortKey="Rutgeerts, P" sort="Rutgeerts, P" uniqKey="Rutgeerts P" first="P" last="Rutgeerts">P. Rutgeerts</name></noRegion></country><country name="Canada"><noRegion><name sortKey="Feagan, B G" sort="Feagan, B G" uniqKey="Feagan B" first="B G" last="Feagan">B G Feagan</name></noRegion></country><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Marano, C W" sort="Marano, C W" uniqKey="Marano C" first="C W" last="Marano">C W Marano</name></region><name sortKey="Adedokun, O J" sort="Adedokun, O J" uniqKey="Adedokun O" first="O J" last="Adedokun">O J Adedokun</name><name sortKey="Guzzo, C" sort="Guzzo, C" uniqKey="Guzzo C" first="C" last="Guzzo">C. Guzzo</name><name sortKey="Johanns, J" sort="Johanns, J" uniqKey="Johanns J" first="J" last="Johanns">J. Johanns</name><name sortKey="Padgett, L" sort="Padgett, L" uniqKey="Padgett L" first="L" last="Padgett">L. Padgett</name><name sortKey="Sandborn, W J" sort="Sandborn, W J" uniqKey="Sandborn W" first="W J" last="Sandborn">W J Sandborn</name><name sortKey="Strauss, R" sort="Strauss, R" uniqKey="Strauss R" first="R" last="Strauss">R. Strauss</name><name sortKey="Zhang, H" sort="Zhang, H" uniqKey="Zhang H" first="H" last="Zhang">H. Zhang</name></country><country name="France"><noRegion><name sortKey="Colombel, J F" sort="Colombel, J F" uniqKey="Colombel J" first="J-F" last="Colombel">J-F Colombel</name></noRegion></country><country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Reinisch, W" sort="Reinisch, W" uniqKey="Reinisch W" first="W" last="Reinisch">W. Reinisch</name></region></country><country name="Australie"><noRegion><name sortKey="Gibson, P R" sort="Gibson, P R" uniqKey="Gibson P" first="P R" last="Gibson">P R Gibson</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002926 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002926 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26119226
|texte= Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26119226" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |